IL18 and neoplasm: We first evaluated nutrient transporter expression in IL18-armored αβ and γδ pCAR-H/T+ T cells, either after expansion for 3 weeks or following two additional re-stimulation cycles on MDA-MB-468 tumor cell monolayers.